Strides Pharma Science Ltd. benchmarking: Performance to industry peers

Financial

	Strides Pharma Scien	Viyash Scientific	Marksans Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	230.0 .	n/a	25.0 .
Number of ANDA's Approved By USFDA	215.0 .	n/a	13.0 .
R&D as a % of Total Sales	1.84 %	0.0	3.0 %
Financials
5 yr Average ROE	30.1 %	4.43 %	17.57 %
5yr average Equity Multiplier	2.62	2.16	1.33
5yr Average Asset Turnover Ratio	0.6	0.95	0.9
5yr Avg Net Profit Margin	12.9 %	0.03 %	14.56 %
Price to Book	3.85	11.6	3.35
P/E	20.77	122.23	24.98
5yr Avg Cash Conversion Cycle	-51.45 Days	49.09 Days	71.65 Days
Inventory Days	69.05 Days	80.25 Days	89.77 Days
Days Receivable	60.35 Days	79.76 Days	65.99 Days
Days Payable	225.58 Days	114.46 Days	88.81 Days
5yr Average Interest Coverage Ratio	0.72	1.93	38.03
5yr Avg ROCE	10.5 %	6.67 %	21.95 %
5yr Avg Operating Profit Margin	12.17 %	7.74 %	20.32 %
5 yr average Debt to Equity	1.01	0.53	0.02
5yr CAGR Net Profit	68.01 %	-25.52 %	10.03 %
5yr Average Return on Assets	10.97 %	0.05 %	13.19 %
Shareholdings
Promoter Holding	27.91 %	61.31 %	43.87 %
Share Pledged by Promoters	27.27 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.36 %	8.52 %	0.02 %
Change in Mutual Fund Holding (3 Yrs)	-2.58 %	6.19 %	3.8 %

Business

	Strides Pharma Scien	Viyash Scientific	Marksans Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Active Pharmaceutical Ingredient 0 Formulations 0 Vitamins & Suppliments 0 Anti-Cancer 0 Anti-Hair Fall 0 Central Nervous System 0 Antibiotics 0 Anti-allergic 0 Miscellaneous 0 Gastro-intestinal 0 Anti-diabetic 0 Cough and colds 0 Cardiovascular system (CVS) 0 Pain management 0	Product Wise Break-Up Vitamins & Suppliments 0 Anti-allergic 0 Anti-Cancer 0 Pain management 0 Formulations 56.23 Miscellaneous 0 Gastro-intestinal 0 Active Pharmaceutical Ingredient (API) 42.77 Cough and colds 0 Antibiotics 0 Anti-diabetic 0 Cardiovascular system (CVS) 0 Central Nervous System 0 Pharmaceutical 0 Anti-Hair Fall 0 Others 1.0	Product Wise Break-Up Vitamins & Suppliments 0 Anti-allergic 0 Anti-Cancer 0 Pain Management 44.0 Formulations 0 Miscellaneous 0 Gastro Intestinal 8.5 Active Pharmaceutical Ingredient 0 Cough and colds 14.0 Antibiotics 0 Anti - Diabetes 1.6 Cardiac Science 9.2 Central Nervous System (CNS) 8.1 Pharmaceutical 0 Anti-Hair Fall 0 Others 14.6
Location Wise Break-Up	Location Wise Break-Up North America 53.68 Europe 21.77 Africa 10.11 Australia 9.63 Asia Pacific 0.49 India 0.35 Turkey 0 LATAM 0 EM 0 Rest of the World 0 Asia 0 Others 3.97	Location Wise Break-Up EM 0 Asia Pacific 28.68 Asia Pacific 0 LATAM 0 Australia 0 North America 0 Europe 45.13 Rest of the World 26.19 India 0 Africa 0 Turkey 0	Location Wise Break-Up EM 0 Asia 0 Asia Pacific 0 LATAM 0 Australia 8.1 North America 54.7 Europe 34.2 Rest of the World 0 India 0 Africa 0 Turkey 0 Others 3.0
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical 100.0	-	-
Customer Segment	Customer Segment Regulated market 83.0 Emerging Market 11.0 Institutional Business 0 Less regulated market 0 OTC 0 Rx 0 Others 6.0	Customer Segment Rx 0 Institutional Business 0 OTC 0 Emerging Market 0 Less regulated market 33.0 Regulated market 67.0	Customer Segment Rx 21.2 Institutional Business 0 OTC 78.8 Emerging Market 0 Less regulated market 0 Regulated market 0
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 43.68 Asia ex India 22.48 North America 18.17 Europe 10.2 Africa 5.48 Australia 0	-	-
Asset Break-Up	Asset Break-Up Pharmaceutical 97.35 Bio-Pharmaceutical 2.65 Rest of the World 0 Asia 0 Europe 0	Asset Break-Up Asia Pacific 43.23 Bio-Pharmaceutical 0 Rest of the World 22.42 Europe 34.35 Pharmaceutical 0	-

Strides Pharma Science Ltd.

Strides Pharma Science Ltd.

Financial

Business

SIGN UP FOR FREE